A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients-Reference-Cited by-同舟云学术

A simple and rapid LC-MS/MS method for therapeutic drug monitoring of cetuximab: a GPCO-UNICANCER proof of concept study in head-and-neck cancer patients

Published:2017-06-02 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Becher François,Ciccolini Joseph,Imbs Diane-Charlotte,Marin Clémence,Fournel Claire,Dupuis Charlotte,Fakhry Nicolas,Pourroy Bertrand,Ghettas Aurélie,Pruvost Alain^ORCID,Junot Christophe,Duffaud Florence,Lacarelle Bruno,Salas Sebastien

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-02821-x.pdf

Reference32 articles.

1. Alorabi, M. et al. EGFR monoclonal antibodies in locally advanced head and neck squamous cell carcinoma: What is their current role? Crit. Rev. Oncol. Hematol. 99, 170–9, doi: 10.1016/j.critrevonc.2015.12.006 (2016).

2. Elez, E. et al. First-Line Treatment of Metastatic Colorectal Cancer: Interpreting FIRE-3, PEAK, and CALGB/SWOG 80405. Curr. Treat. Options Oncol. 16, 52, doi: 10.1007/s11864-015-0369-x (2015).

3. Fracasso, P. M. et al. A phase 1 escalating single-dose and weekly fixed-dose study of cetuximab: pharmacokinetic and pharmacodynamic rationale for dosing. Clin. Cancer Res. 13, 986–93, doi: 10.1158/1078-0432.CCR-06-1542 (2007).

4. Pointreau, Y. et al. Cetuximab Pharmacokinetics Influences Overall Survival in Patients With Head and Neck Cancer. Ther. Drug Monit. 38, 567–72, doi: 10.1097/FTD.0000000000000321 (2016).

5. Azzopardi, N. et al. Cetuximab pharmacokinetics influences progression-free survival of metastatic colorectal cancer patients. Clin. Cancer Res. 17, 6329–37, doi: 10.1158/1078-0432.CCR-11-1081 (2011).

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generic Enrichment Method for Liquid Chromatography-Multiple Reaction Monitoring-Mass Spectrometry Assay for Quantitative Measurement of Biological Therapeutics in Serum;Pharmaceutical Research;2024-08-22

2. High-throughput, low-cost quantification of 11 therapeutic antibodies using caprylic acid precipitation and LC-MS/MS;Analytica Chimica Acta;2024-07

3. A robust and validated LC–MS/MS method for the quantification of ramucirumab in rat and human serum using direct enzymatic digestion without immunoassay;Journal of Chromatography B;2024-02

4. Recent developments in mass-spectrometry-based targeted proteomics of clinical cancer biomarkers;Clinical Proteomics;2024-01-30

5. Phage Display Technology: A Way Forward for Production of Recombinant Monoclonal Antibodies;Microbial Products for Health and Nutrition;2024